(TEAM) Atlassian - Ratings and Ratios

Exchange: NASDAQ • Country: Australia • Currency: USD • Type: Common Stock • ISIN: US0494681010

TEAM: Software, Management, Tools, Systems, Products, Solutions

Atlassian Corporation is a leading provider of collaboration software for teams, offering a suite of tools that enhance productivity and teamwork. Their product lineup includes Jira, a comprehensive project management system that bridges technical and business teams, enabling better planning and tracking of projects. Confluence serves as a collaborative workspace where organizations can create, organize, and share information seamlessly. Trello provides a flexible platform for structuring tasks and projects, catering to both individual and team workflows. Additionally, Atlassian has acquired Loom, which facilitates asynchronous video communication, allowing teams to share ideas and feedback efficiently.

The company extends its offerings with specialized tools such as Jira Service Management, designed for service desks across various teams like IT and legal, and Jira Align, which helps enterprises adapt to dynamic conditions with a focus on value creation. Their portfolio also includes Bitbucket, an enterprise-grade git solution for code management; Atlassian Access, enhancing security across all cloud products; Jira Product Discovery for prioritization; and Compass, a developer portal offering real-time insights into engineering outputs. Other notable products are Bamboo, Crowd, Crucible, Fisheye, Opsgenie, Sourcetree, and Statuspage.

Founded in 2002 and headquartered in Sydney, Australia, Atlassian is listed on the NASDAQ under the ticker TEAM. As a key player in the application software industry, they serve a global customer base, emphasizing cloud-based solutions and robust security features, which are critical for enterprise clients. With a market capitalization of over $82 billion, Atlassians financial metrics include a forward P/E of 94.34 and a P/S ratio of 18.12, providing investors with a clear view of their valuation landscape. Their focus on innovation and customer-centric solutions positions them as a significant player in the software industry.

Additional Sources for TEAM Stock

TEAM Stock Overview

Market Cap in USD 57,113m
Sector Technology
Industry Software - Application
GiC Sub-Industry Application Software
IPO / Inception 2015-12-10

TEAM Stock Ratings

Growth 5y 26.8%
Fundamental 5.55%
Dividend 0.0%
Rel. Strength 10.2
Analysts 4.17/5
Fair Price Momentum 191.72 USD
Fair Price DCF 191.11 USD

TEAM Dividends

No Dividends Paid

TEAM Growth Ratios

Growth Correlation 3m -33%
Growth Correlation 12m 65.4%
Growth Correlation 5y -13.1%
CAGR 5y 10.47%
CAGR/Max DD 5y 0.14
Sharpe Ratio 12m -0.16
Alpha 1.63
Beta 0.912
Volatility 63.42%
Current Volume 2271.2k
Average Volume 20d 2404k
What is the price of TEAM stocks?
As of April 01, 2025, the stock is trading at USD 212.21 with a total of 2,271,222 shares traded.
Over the past week, the price has changed by -9.55%, over one month by -25.35%, over three months by -12.81% and over the past year by +9.74%.
Is Atlassian a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Atlassian is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.55 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TEAM as of April 2025 is 191.72. This means that TEAM is currently overvalued and has a potential downside of -9.66%.
Is TEAM a buy, sell or hold?
Atlassian has received a consensus analysts rating of 4.17. Therefor, it is recommend to buy TEAM.
  • Strong Buy: 14
  • Buy: 7
  • Hold: 9
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TEAM stock price target?
According to ValueRays Forecast Model, TEAM Atlassian will be worth about 213.4 in April 2026. The stock is currently trading at 212.21. This means that the stock has a potential upside of +0.57%.
Issuer Forecast Upside
Wallstreet Target Price 339.7 60.1%
Analysts Target Price 283.8 33.7%
ValueRay Target Price 213.4 0.6%